Design Therapeutics (DSGN)'s 30-day implied volatility (IV30) was 53.9% at the close on October 23, 2026, down from 62.1% the day before, against a 52-week range of 46.0% to 109.6%. Its 20-day historical volatility was 61.3%.
Data as of October 23, 2026.